Ken Yoshida

Dr. Ken Yoshida


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KMKazuhiro Maeda
Kazuhiro Maeda
KYKen Yoshida
Ken Yoshida
TNTetsuro Nishizawa
Tetsuro Nishizawa
KOKazuhiro Otani
Kazuhiro Otani
YYYu Yamashita
Yu Yamashita
MSMitsuru Saito
Mitsuru Saito
Rheumatoid arthritis (RA) is an inflammatory disease characterized by a variety of symptoms and pathologies often presenting with polyarthritis. The primary symptom in the initial stage is joint swelling due to synovitis. With disease progression, cartilage and bone are affected to cause joint deformities. Advanced osteoarticular destruction and deformation can cause irreversible physical disabilities. Physical disabilities not only deteriorate patients’ quality of life but also have substantial medical economic effects on society. Therefore, prevention of the progression of osteoarticular destruction and deformation is an important task. Recent studies have progressively improved our understanding of the molecular mechanism by which synovitis caused by immune disorders results in activation of osteoclasts; activated osteoclasts in turn cause bone destruction and para-articular osteoporosis. In this paper, we review the mechanisms of bone metabolism under physiological and RA conditions, and we describe the effects of therapeutic intervention against RA on bone.

18 August 2010 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
KYKen Yoshida
Ken Yoshida
DKDaitaro Kurosaka
Daitaro Kurosaka
KJKensuke Joh
Kensuke Joh
SMSatoshi Matsushima
Satoshi Matsushima
ETEigo Takahashi
Eigo Takahashi
AYAkio Yamada
Akio Yamada
Objective: To investigate whether fasciitis is histopathologically demonstrable in patients with dermatomyositis (DM), and to analyze the process of inflammatory progression in myopathy accompanying DM.Methods: STIR or fat‐suppressed T2‐weighted magnetic resonance imaging (MRI) and en bloc biopsy were performed in 14 patients with newly diagnosed adult‐onset DM. The severity of inflammatory cell infiltration around the fascial and intramuscular small blood vessels was evaluated using the total vascular inflammation score (TVIS).Results: In all patients, MRI revealed abnormal hyperintensity in the fascia and in marginal sites of the muscle, predominantly over central sites. En bloc biopsy revealed the presence of fasciitis in most of the patients, as shown by inflammatory infiltrates around the fascial small blood vessels. In those patients who underwent en bloc biopsy earlier than 2 months after the appearance of muscle symptoms, the TVIS of the fascia was significantly higher than the TVIS of the muscle. In contrast, in those patients who underwent en bloc biopsy ≥2 months after muscle symptom onset, the TVIS of the fascia did not differ significantly from the TVIS of the muscle.Conclusion: Fasciitis was histopathologically demonstrated in patients with newly diagnosed adult‐onset DM as early as 2 months after the onset of muscle symptoms. These results indicate that fasciitis is a common lesion of DM and suggest that the fascial microvasculature is the primary site of inflammatory cell infiltration in DM. Fasciitis may contribute to muscle symptoms in patients with DM without myositis.

28 March 2019 in RMD Open
Verified
Journal Article
Open access
PDF file
TUTaro Ukichi
Taro Ukichi
KYKen Yoshida
Ken Yoshida
SMSatoshi Matsushima
Satoshi Matsushima
GKGo Kawakami
Go Kawakami
KNKentaro Noda
Kentaro Noda
DKDaitaro Kurosaka
Daitaro Kurosaka
Objective To define the characteristic findings on MRI of skeletal muscles in patients with dermatomyositis (DM) relative to those in patients with other idiopathic inflammatory myopathies (IIMs) and to assess their diagnostic performance in DM. Methods Thirty-six patients with DM, 17 patients with amyopathic DM, 19 patients with polymyositis and 16 patients with non-IIM classified by the 2017 European League Against Rheumatism/American College of Rheumatology criteria were included in this study. The following MRI findings (short-tau inversion recovery [STIR] and gadolinium-enhanced fat-suppressed T1-weighted imaging [Gd-T1WI]) for proximal limb muscles were compared between the disease groups and between myositis-specific autoantibodies/myositis-associated autoantibodies (MSAs/MAAs)-positive and MSAs/MAAs-negative groups: structures with high signal intensity (HSI) (subcutaneous, fascia, muscle); distributions of HSI areas in muscle (diffuse, patchy, peripheral) and patterns of HSI in muscle (honeycomb, foggy, strong HSI). Univariate, multivariate and receiver-operating characteristic [ROC] analyses were performed to assess the diagnostic performance of MRI in DM. Results The characteristic MRI findings in patients with DM were subcutaneous HSI, fascial HSI, peripheral distribution and honeycomb pattern. The MRI findings in the MSAs/MAAs-positive group included more frequent fascial HSI but less frequent foggy pattern compared with the MSAs/MAAs-negative group. Likelihood of DM score ≥ 3 (obtained by counting the number of characteristic MRI findings in patients with DM) showed good diagnostic performance in DM (STIR: sensitivity 72.2%, specificity 88.5%, area under ROC curve [AUC] 84.9%; Gd-T1WI: sensitivity 81.2%, specificity 91.5%, AUC 89.9%). Conclusion The characteristic MRI findings of skeletal muscles can predict patients with DM as well as patients with MSAs/MAAs.

8 September 2016 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
HIHaruyasu Ito
Haruyasu Ito
KNKentaro Noda
Kentaro Noda
KYKen Yoshida
Ken Yoshida
KOKazuhiro Otani
Kazuhiro Otani
MYMasayuki Yoshiga
Masayuki Yoshiga
DKDaitaro Kurosaka
Daitaro Kurosaka
Prokineticin 2 (PK2) expression is upregulated in mice with collagen-induced arthritis (CIA), an animal model of rheumatoid arthritis. The purpose of our study was to investigate the effects of PK2 inhibition on CIA. PK2, prokineticin receptor (PKR) 1, and PKR2 mRNA transcripts in the joints of CIA mice were measured by real-time PCR on Days 21, 28, and 35 (n = 15/day). Localization of PKR1 and PKR2 proteins was examined immunohistochemically. PKRA7, a PK2 antagonist, was administered intraperitoneally for 2 weeks to CIA mice, and the severity of arthritis was compared between treated (n = 12) and untreated (n = 12) mice. The gene expression levels of inflammatory cytokines IL-1β, IL-6, TNF-α, and VEGF were also measured by real-time PCR and compared between treated (n = 6) and untreated (n = 6) CIA mice. The data was statistically analyzed, and P values of less than 0.05 were considered significant. In the thickened synovial membrane, PKR1 protein was expressed in infiltrating neutrophils, while PKR2 expression was found in macrophage-like mononuclear cells. PK2 gene expression was significantly more pronounced on Days 28 and 35 than on Day 21 (2.15 and 2.03 versus 1.00, P = 0.0311 and 0.0247; Dunn’s multiple comparison). PKR2 gene expression levels were significantly higher on Days 28 and 35 compared to Day 21 (25.4 and 39.3 versus 1.0, P = 0.002 and < 0.0001; Dunn’s multiple comparison). Administration of PKRA7 suppressed the severity of arthritis (P < 0.001; two-way analysis of variance). A gene expression analysis of inflammatory cytokines revealed significantly reduced IL-1β and lL-6 expression in the joints of PKRA7-treated mice compared to untreated mice (0.1 versus 1.0, P = 0.0043 and 0.04 versus 1.0, P = 0.0022, respectively; Mann-Whitney test). PK2 inhibition suppressed arthritis in mice with CIA.

29 February 2008 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
KYKen Yoshida
Ken Yoshida
DKDaitaro Kurosaka
Daitaro Kurosaka
IKIsamu Kingetsu
Isamu Kingetsu
KHKenichiro Hirai
Kenichiro Hirai
AYAkio Yamada
Akio Yamada

28 November 2016 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
KYKen Yoshida
Ken Yoshida
MNMakiko Nishioka
Makiko Nishioka
SMSatoshi Matsushima
Satoshi Matsushima
KJKensuke Joh
Kensuke Joh
YOYosuke Oto
Yosuke Oto
DKDaitaro Kurosaka
Daitaro Kurosaka